Tchaikapharma High Quality Medicines AD Logo

Tchaikapharma High Quality Medicines AD

Develops and manufactures generic and in-licensed pharmaceutical products.

THQM | BSOBGN

Overview

Corporate Details

ISIN(s):
BG1100008074
LEI:
5299003VDHTK75D1JE38
Country:
Bulgaria
Address:
бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София

Description

Tchaikapharma High Quality Medicines AD is a pharmaceutical company that develops and manufactures generic and in-licensed medicinal products. The company focuses on producing affordable, contemporary pharmaceuticals with a proven cost-effectiveness ratio to combat socially significant diseases. Its product portfolio targets a range of therapeutic areas, with a significant focus on cardiovascular conditions, including arterial hypertension, angina pectoris, and thrombosis. Other areas of specialization include treatments for cerebrovascular disease, Parkinson's disease, and metabolic syndrome, as well as anesthetics and anti-inflammatory drugs. The company is also a manufacturer of complex generics, such as polypills (fixed-dose combination medications).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-15 23:00
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
English 47.8 KB
2024-04-15 23:00
609557-7TH_2023 CONS_BG_signed.xls
Bulgarian 719.5 KB
2024-04-15 23:00
609559-7TH_2023 CONS_EN_signed.xls
Bulgarian 235.0 KB
2024-04-15 23:00
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
Bulgarian 6.4 MB
2024-03-26 23:00
608037-SPRAVKA_1_IND_GFO_6M.xls
Bulgarian 722.0 KB
2024-03-26 23:00
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
Bulgarian 21.8 MB
2023-07-12 23:00
7TH_2022 CONS_BG.xls
Bulgarian 718.0 KB
2023-06-07 23:00
SPRAVKA_1_IND_GFO_6M_signed.xls
Bulgarian 778.5 KB
2023-06-07 23:00
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
Bulgarian 37.0 MB
2022-07-26 23:00
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
Bulgarian 5.7 MB
2022-07-26 23:00
7TH_2021_signed.xls
Bulgarian 939.0 KB
2022-07-26 23:00
5299003VDHTK75D1JE38-20211231-BG-CON.zip
Bulgarian 3.2 MB
2022-07-26 23:00
7TH_2021 CONS.xls
Bulgarian 900.0 KB

Automate Your Workflow. Get a real-time feed of all Tchaikapharma High Quality Medicines AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tchaikapharma High Quality Medicines AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tchaikapharma High Quality Medicines AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.